Active surveillance for prostate cancer: a narrative review of clinical guidelines-Reference-Cited by-同舟云学术

Active surveillance for prostate cancer: a narrative review of clinical guidelines

Published:2016-01-27 Issue:3 Volume:13 Page:151-167
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Bruinsma Sophie M., ,Bangma Chris H.,Carroll Peter R.,Leapman Michael S.,Rannikko Antti,Petrides Neophytos,Weerakoon Mahesha,Bokhorst Leonard P.,Roobol Monique J.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/nrurol.2015.313.pdf

Reference53 articles.

1. Center, M. M. et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 61, 1079–1092 (2012).

2. Kim, T. H. et al. Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols. Int. J. Urol. 21, 377–381 (2013).

3. Schroder, F. H. et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384, 2027–2035 (2014).

4. Duffy, M. J. PSA in screening for prostate cancer: more good than harm or more harm than good? Adv. Clin. Chem. 66, 1–23 (2014).

5. Stenman, U. H. et al. Prognostic value of serum markers for prostate cancer. Scand. J. Urol. Nephrol. Suppl. 216, 64–81 (2005).

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision-making experiences of patients and partners opting for active surveillance in esophageal cancer treatment;Patient Education and Counseling;2024-10

2. Case report: Two cases of prostate adenocarcinoma progressing to rare sarcomatoid carcinoma with normal PSA levels following endocrine therapy;Frontiers in Oncology;2024-09-05

3. Investigating miR-6880-5p in extracellular vesicle from plasma as a prognostic biomarker in endocrine therapy-treated castration-resistant prostate cancer;BMC Cancer;2024-07-29

4. [68Ga]Ga‑PSMA‑617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1–2 prostate cancer at biopsy;Cancer Imaging;2024-07-04

5. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis;Cancer Medicine;2024-03-28